BioMérieux: FDA clearance for Vidas TBI test
This serum test enables the evaluation and management of patients with mild traumatic brain injury, including concussion.
The test helps reduce the number of brain scans (CT scans) required for patients with mild traumatic brain injury by predicting the absence of post-traumatic intracranial lesions.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction